A resolution supporting the designation of July 15, 2016, as "Leiomyosarcoma Awareness Day".

Bill: 114-sres-545
Sponsor: full_name: Sen. Stabenow, Debbie [D-MI]
Introduced: 2016-07-14
Policy area: Health
Subjects: Cancer

Commemorative events and holidays

Congressional tributes

Health personnel

Health promotion and preventive care

Medical research

Musculoskeletal and skin diseases
Latest action: action_date: 2016-07-14
text: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S5193-5194; text as passed Senate: CR S5175-5176)

Summaries:
action_date: 2016-07-14
action_desc: Introduced in Senate
text: <p> Expresses support for the designation of July 15, 2016, as Leiomyosarcoma Awareness Day. (Leiomyosarcoma is cancer that arises from smooth muscle tissue, most commonly originating in the uterus, stomach, intestine, or blood vessels.)</p> <p>Recognizes the challenges faced by leiomyosarcoma patients and commends the dedication of organizations, volunteers, researchers, and caregivers working to improve the quality of life of leiomyosarcoma patients and their families.</p>

action_date: 2016-07-14
action_desc: Passed Senate without amendment
text: <p>(This measure has not been amended since it was introduced. The summary of that version is repeated here.)</p> <p> Expresses support for the designation of July 15, 2016, as Leiomyosarcoma Awareness Day. (Leiomyosarcoma is cancer that arises from smooth muscle tissue, most commonly originating in the uterus, stomach, intestine, or blood vessels.)</p> <p>Recognizes the challenges faced by leiomyosarcoma patients and commends the dedication of organizations, volunteers, researchers, and caregivers working to improve the quality of life of leiomyosarcoma patients and their families.</p>

tv_txt: III 114th CONGRESS 2d Session S. RES. 545 IN THE SENATE OF THE UNITED STATES July 14, 2016 Ms. Stabenow submitted the following resolution; which was considered and agreed to RESOLUTION Supporting the designation of July 15, 2016, as Leiomyosarcoma Awareness Day .

Whereas a soft tissue sarcoma is a rare type of cancer, accounting for approximately 1 percent of newly diagnosed cancers; Whereas Leiomyosarcoma (referred to in this preamble as LMS ) is a malignant subtype of soft tissue sarcoma that originates in smooth muscle, often in the walls of blood vessels; Whereas LMS is highly aggressive and can be found throughout the body, but is especially concentrated in the uterus, abdominal cavity, and extremities; Whereas the National Institutes of Health classifies LMS as a rare disease; Whereas most oncologists will only see a few cases of LMS throughout a career; Whereas the causes of LMS are still unknown; Whereas LMS is largely resistant to standard chemotherapeutic agents, radiation treatment, and current immunotherapies; Whereas multidisciplinary care coordination teams, because of their expertise and experience, are critical to the health of LMS patients; Whereas LMS research will allow medical professionals to improve the quality of care for LMS patients, lead to better clinical outcomes, and promote longer survival for LMS patients; and Whereas increased education and awareness about LMS will contribute to the well-being of the communities of the United States: Now, therefore, be it

That the Senate— (1) supports the designation of July 15, 2016, as Leiomyosarcoma Awareness Day ; (2) recognizes the challenges faced by Leiomyosarcoma patients; and (3) commends the dedication of organizations, volunteers, researchers, and caregivers across the country working to improve the quality of life of Leiomyosarcoma patients and the families of Leiomyosarcoma patients.